GlassScriptPhysician profile
Laura Perez Gonzalez
NPI 1790561397
$1,267.64
in general payments reported to CMS, 2019-2025
14 companies · $585 in 2025
The $585 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13.16 · 2024: $669 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021 · Travel and Lodging: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,020.57 |
| Travel and Lodging | $247.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $489.52 | 2023-2025 | Sprint Pns System |
| Averitas Pharma INC. | $274.36 | 2024-2025 | Qutenza |
| Painteq LLC | $111.22 | 2024 | Painteq |
| Medtronic, INC. | $93.84 | 2024-2025 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $71.50 | 2024-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $42.04 | 2024-2025 | Proclaim, Octrode |
| Si-Bone, INC. | $35.57 | 2024-2025 | |
| Atricure, INC. | $31.51 | 2024-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Astrazeneca Pharmaceuticals LP | $24.28 | 2024 | Flumist Quadrivalent |
| Vertex Pharmaceuticals Incorporated | $22.11 | 2024 | |
| Curonix LLC | $21.01 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $20.00 | 2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $16.66 | 2024 | Senza |
| International Rehabilitative Sciences, INC | $14.02 | 2024 | Rs 4i Plus Sequential Stimulator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.